Navigation Links
The QIAGEN Guide to Animal Cell Culture

Part II: Safety and handling considerations for animal cell culture

Welcome to the second of a new series of articles aimed at providing useful hints for culturing animal cells. This article describes considerations for working with animal cell cultures as well as information on cell culture contamination. The series will continue in future issues of QIAGEN News with information on cell culture growth conditions, followed by cell culture protocols.

Legislation and regulatory guidelines

Before undertaking any work with human or animal tissue (e.g., to establish a primary cell culture), it is necessary to ensure that the nature of the work conforms to the appropriate medical-ethical and animal-experiment legislation and guidelines. It may be necessary to seek approval from the relevant regulatory authorities and/or individuals.

Safety considerations and biohazards

When working with potentially hazardous material, it is important to be aware of the possible risks associated with both the material and the experimental protocol. All cell cultures are considered a biohazard because of their potential to harbor an infectious agent (e.g., a virus). The degree of hazard depends on the cells being used and the experimental protocol. Primary cell cultures in particular should be handled carefully as these cultures have a high risk of containing undetected viruses. Although commonly used cell lines are generally assumed to be free of infectious agents, care should still be exercised when working with these cell lines as it is possible that they contain infectious agents, such as latent viruses. Cell cultures used to stud
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. The QIAGEN Guide to Animal Cell Culture
2. The QIAGEN Guide to Animal Cell Culture
3. The QIAGEN Guide to Animal Cell Culture
4. The QIAGEN Guide to Animal Cell Culture
5. The QIAGEN Guide to Animal Cell Culture
6. QIAGEN Instrument Service insist on the best in service and support
7. QIAGEN Multiplex PCR Handbook
8. QIAGEN Multiplex PCR Kit
9. QIAGEN Plasmid Kits
10. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
11. QIAGEN PCR CloningPlus Kit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The QIAGEN Guide Animal Cell Culture

(Date:11/24/2009)...ire/--BlueMarbleEnergyCorp.announcedtodaythattheco...ererecentlyawarded$2millionbyWashingtonState,sComm...ublicpartnershiptoconstructthestate,sfirstspecialt...Thisinvestmentwillsignificantlyspeedthedevelopment...unty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wearegr...
(Date:11/24/2009)...wswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY...y,announcedthatithassubmittedaMAAtotheEuropeanMedi...ereplacementtherapyindevelopment,forthetreatmentof...ationforvelaglucerasealfathathasbeensubmitted,with..., Basedonaglobalsupplyshortageofthecurrentlyapp...
(Date:11/24/2009)...ram Connects Customers with Partners Validated to ...otek Products , Ottawa, O...ading provider of products for biological sample c...nounced its new global partner program. The progra...s partner community and is designed to help partne...
(Date:11/23/2009)...nk of it as origami very high-tech origami. , Re...oped a technique for fabricating three-dimensional...films by coupling photolithography and a self-fold...he films, only a few microns thick, offer mechanic...ieces of the same material. , "This is a complete...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...elior Discovery, Inc. announced today that it has ...ch Melior’s in-vivo theraTRACE indications d...rapeutic activity of selected AstraZeneca compound...s Wire EON) August 19, 2008 -- "Our agreemen...to deliver value to AstraZeneca through the applic...
...uska Therapeutics,Inc. (OTC Bulletin Board: DSKA) ...o, M.D., M.B.A. will present at the fourth annual ...st 19, 2008 at the Loews Lake,Las Vegas Resort in ...ed,for 1:30 p.m. PDT. Dr. Kuo will also be availab...he presentation with streaming video and PowerPoin...
...aturally Raised Pork Back to Farm of Origin, NORT...,Premium Brand, a leader in premium, all-natural f...y to track DNA for reliable and accurate,traceabil.... Nature,s,Premium will use IdentiGEN,s DNA TraceB...traceback system, for indisputable product,verific...
Other Biology Technology:Duska Therapeutics to Present at Noble Financial Equity 'M.A.D. MAX' Conference on Tuesday, August 19th at 1:30 p.m. PDT 2Duska Therapeutics to Present at Noble Financial Equity 'M.A.D. MAX' Conference on Tuesday, August 19th at 1:30 p.m. PDT 3Nature's Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity 2Nature's Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity 3Nature's Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity 4
(Date:11/23/2009)...vailable for the H1N1 virus has been sent to vacci...cination marks the first time vaccine has been sen..., Iowa State University,s Hank Harris, professor...mer and has been shipping preventive doses to swin...al weeks., The latest vaccines were shipped to a...
(Date:11/23/2009)...iversity of Alabama at Birmingham (UAB) researcher... medical conditions (co-morbidity) do not explain ...icans compared to Caucasians who also have colon c...ancer , a journal of the American Cancer Society. ...-morbidity are independent predictors of poor surv...
(Date:11/23/2009)...medical engineer and cardiologist Tzung "John" Hsi...distinguish cardiac emergencies requiring immediat...ugs and lifestyle change. , Angiograms, images m...g the heart, offer an inside view of the interior ...vealing deposits of a dangerous fatty substance ca...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 1Palomar Medical Reports Financial Results for Second Quarter 2009 53208 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 3Palomar Medical Reports Financial Results for Second Quarter 2009 53208 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 5Palomar Medical Reports Financial Results for Second Quarter 2009 53208 6Palomar Medical Reports Financial Results for Second Quarter 2009 53208 7Palomar Medical Reports Financial Results for Second Quarter 2009 53208 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 1CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 3CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 4CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 5CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 6CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 7CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 9CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 10CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 11CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 12CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 13CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 14CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 15AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 1AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 2AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 3AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 4
...niversity of Michigan research team has found that...wound using gene therapy helped generate bone arou...e February issue of the journal Molecular Therapy....acing a tooth takes more than simply implanting a ...e to anchor the new tooth in place. Such reconstru...
...trary to the prevailing belief that the HIV epidem...ew study suggests that HIV spread via at least six...ansmission chains. The findings, published in the ...ademy of Sciences, also suggest that antiviral the...h of the epidemic and that changes in sexual behav...
...ey mechanism in the passing of genetic material fr... been identified by a team of Berkeley researchers...s, called kinetochores, can recognize and stay att...of biological cells that are responsible for the f...ision. , "In test tube experiments, we,ve found t...
Other Biology News:Gene therapy promising for growing tooth-supporting bone 2Gene therapy promising for growing tooth-supporting bone 3HIV-1 spread through six transmission lines in the UK 2HIV-1 spread through six transmission lines in the UK 3Key mechanism in genetic inheritance during cell division identified 2Key mechanism in genetic inheritance during cell division identified 3
Lyophilization Stabilizer from GenScript Corporation
Coating Stabilizer from GenScript Corporation
... the smallest thermal cyclers on the market, which...0 samples) or 0.2ml microtube (25 samples) block ...f 3.6C/sec and 2.0C/sec respectively Proven in re...ming with new quick dial facility Built with spa...
SuperFreeze Peroxidase Conjugate Stabilizer from Pierce Biotechnology, Inc.
Biology Products: